Medivir to present at the Wainwright Annual Global Investment Conference

On September 10, 2021 Medivir AB (NASDAQ Stockholm: MVIR) reported that the company will present at the virtual meeting H.C. Wainwright Annual Global Investment Conference, September 13-15 (Press release, Medivir, SEP 10, 2021, https://www.prnewswire.com/news-releases/medivir-to-present-at-the-wainwright-annual-global-investment-conference-301373196.html [SID1234587565]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

The presentation will be available through Medivir´s website; www.medivir.com.

More information about the event is available at the organizer’s website: View Source

Use the contact form at the top or bottom of this page to book a free demo to 1stOncology™, an all inclusive cancer drug development intelligence platform from BioSeeker. The platform provides value in oncology for you in areas such as:

Target scouting
Indication selection & expansion
Combinatorial drug settings
Drug repositioning
First in class analysis
Compound cross over analysis
Competitive analysis
Pathway analysis

and much more...

1stOncology is recognized as a
Top 10 Global Pharma Analytic Provider

Continue your journey with 1stOncology by accessing our Free Leading Cancer Conference Whitepapers, signing up for our Free Weekly Newsletter and requesting a Free Demo to see how we can help you be 1st in Oncology!